WuXi PharmaTech’s analytical and stability testing facilities in Shanghai Waigaoqiao Free Trade Zone, have passed a GMP inspection by the FDA. The inspection also included clinical trial materials manufacturing for drug products (CTM), packaging and labeling facilities, which were deemed compliant.   “This favorable FDA inspection outcome, in addition to last year’s MPA (EMA) approval, reflects the quality of our analytical and stability testing and CTM facilities, the robustness of ...